Fast Five Quiz: Hypertension Practice Essentials

Yasmine S. Ali, MD, MSCI


March 19, 2020

According to ACC/AHA guidelines, women with hypertension who become pregnant, or are planning to become pregnant, should be transitioned to methyldopa, nifedipine, and/or labetalol. Women with hypertension who become pregnant should not be treated with ACE inhibitors, ARBs, or direct renin inhibitors. Lifestyle modifications are generally sufficient for the management of pregnant women with stage 1 hypertension who are at low risk for cardiovascular complications during pregnancy.

Simultaneous use of an ACE inhibitor, ARB, and/or renin inhibitor is possibly harmful and is not recommended among patients with hypertension. Beta-blockers are no longer considered first-line therapy for hypertension, but these agents can be used in cases with compelling indications aside from hypertension, such as systolic heart failure.

According to ACC/AHA guidelines, aldosterone antagonists are preferred agents in primary aldosteronism and resistant hypertension.

Read more about the pharmaceutical treatment of hypertension.

This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases article Hypertension.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.